Newsmeme!
Discover News you didn't know existed

• home
• news
• tagging
• how it works
• about
• data

Lymphomas

News

ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide

Published November 17, 2008, 4:35 am, Business Wire via Yahoo! Finance

LONDON----ZIOPHARM Oncology, Inc. announced today that it presented positive data from a Phase I study of palifosfamide in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society meeting held in London, UK, November 13 to 15.

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery

Related Lymphomas Stories

From Various News Sources

ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide - Phramalive.com
Palifosfamide active as single agent and in combination LONDON--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin ...

ZIOP: Presents Positive Data from Studies of Palifosfamide at ... - TradingMarkets.com
ZIOPHARM Oncology, Inc. (ZIOP) presented positive data from a Phase I study of palifosfamide (Zymafos(TM)) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society (CTOS) meeting held in London, UK, November 13-15. Also ...

Related Social Bookmarks

None found at this time.